G1 Therapeutics to Provide Second Quarter 2021 Financial Results and Business Update on August 4, 2021
28 July 2021 - 10:00PM
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology
company, will host a webcast and conference call to provide a
corporate and financial update for the second quarter of 2021 on
Wednesday, August 4, 2021 at 4:30 p.m. ET.
The live call may be accessed by dialing (866) 763-6020
(domestic) or (210) 874-7713 (international) and entering the
conference code: 3553037. The live and archived webcast will be
available on the Events & Presentations page of
http://www.g1therapeutics.com.
About G1 TherapeuticsG1 Therapeutics, Inc. is a
commercial-stage biopharmaceutical company focused on the
development and commercialization of next generation therapies that
improve the lives of those affected by cancer, including the
Company’s first commercial product, COSELA™ (trilaciclib). G1 has a
deep clinical pipeline and is executing a tumor-agnostic
development plan evaluating COSELA in a variety of solid tumors,
including colorectal, breast, lung, and bladder cancers. G1
Therapeutics is based in Research Triangle Park, N.C. For
additional information, please visit www.g1therapeutics.com and
follow us on Twitter @G1Therapeutics.
G1 Therapeutics™ and the G1 Therapeutics logo are trademarks of
G1 Therapeutics, Inc.
G1 Therapeutics Contacts:
Will RobertsVice PresidentInvestor Relations and Corporate
Communications(919) 907-1944 wroberts@g1therapeutics.com
Rebecca LevineDirector, Corporate Communications and Public
Relations(919) 667-8711 rlevine@g1therapeutics.com
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Apr 2024 to May 2024
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From May 2023 to May 2024